MLB: White Sox sign RHP Mike Clevinger to one-year deal

Date:

Share post:


Right-hander Mike Clevinger agreed to terms with the Chicago White Sox on a one-year, $12 million contract Sunday.

Per the White Sox, Clevinger will receive $8 million in 2023 with a mutual $12 million option for 2024 that includes a $4 million buyout.

Clevinger, who turns 32 later this month, went 7-7 with a 4.33 ERA in 23 appearances (22 starts) for the San Diego Padres last season.

The former fourth-round draft pick by the Los Angeles Angels in 2011 spent his first 4 1/2 seasons in Cleveland before his young career hit a snag. He was moved to the Padres at the 2020 trade deadline after he had been suspended for violating team COVID-19 protocol.

Clevinger then pitched just four games with the Padres in 2020 before he needed Tommy John surgery, forcing him to miss the entire 2021 campaign.

In 128 career appearances (114 starts), Clevinger has gone 51-30 with a 3.39 ERA and 694 strikeouts over 656 2/3 innings.

The White Sox were projected to be a World Series contender last season but missed the playoffs with an 81-81 record. Manager Tony La Russa left the team for health considerations on Aug. 31 and did not return. Pedro Grifol was hired as manager on Nov. 1.

–Field Level Media

spot_img

Related articles

MLB: Max Muncy hits 3 homers as Dodgers crush Braves

Max Muncy delivered his first career three-homer game, Shohei Ohtani and Andy Pages also went deep and the...

MLB: Losing streak over, Pirates hunting more offense vs. Rockies

The Pittsburgh Pirates have one fewer funk to shed entering Sunday's game against the visiting Colorado Rockies in...

MLB: Twins eye 13th straight win in series finale vs. Red Sox

The Minnesota Twins are the hottest team in the majors and will attempt to extend their winning streak...

MLB: Athletics blast Marlins with six homers, win 20-4

Brent Rooker and Brett Harris belted two home runs apiece, while 10 Oakland players registered at least one...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.